Brokerages Set Encompass Health Co. (NYSE:EHC) Target Price at $83.22

Encompass Health Co. (NYSE:EHC - Get Free Report) has been given an average rating of "Buy" by the eight brokerages that are currently covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $85.44.

A number of research analysts recently weighed in on the stock. Mizuho increased their price objective on shares of Encompass Health from $93.00 to $95.00 and gave the company a "buy" rating in a research report on Thursday. William Blair restated an "outperform" rating on shares of Encompass Health in a research report on Wednesday, February 7th. Truist Financial upped their target price on shares of Encompass Health from $82.00 to $86.00 and gave the company a "buy" rating in a report on Friday, February 9th. Stephens reaffirmed an "overweight" rating and set a $85.00 target price on shares of Encompass Health in a report on Tuesday, January 16th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and set a $83.00 target price on shares of Encompass Health in a report on Friday, February 9th.

Institutional Trading of Encompass Health

Several large investors have recently made changes to their positions in the business. Equitable Trust Co. boosted its holdings in shares of Encompass Health by 69.4% in the 1st quarter. Equitable Trust Co. now owns 6,429 shares of the company's stock valued at $531,000 after acquiring an additional 2,634 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Encompass Health by 75.7% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 720,173 shares of the company's stock valued at $59,472,000 after acquiring an additional 310,285 shares during the last quarter. Rice Hall James & Associates LLC boosted its holdings in Encompass Health by 15.1% during the first quarter. Rice Hall James & Associates LLC now owns 55,111 shares of the company's stock worth $4,551,000 after buying an additional 7,225 shares in the last quarter. Louisiana State Employees Retirement System boosted its holdings in Encompass Health by 2.5% during the first quarter. Louisiana State Employees Retirement System now owns 28,900 shares of the company's stock worth $2,387,000 after buying an additional 700 shares in the last quarter. Finally, Stonegate Investment Group LLC purchased a new stake in Encompass Health during the first quarter worth $229,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Stock Down 0.1 %

Shares of NYSE EHC traded down $0.06 during midday trading on Thursday, hitting $82.74. The stock had a trading volume of 1,488,277 shares, compared to its average volume of 671,911. The business's 50 day moving average is $78.07 and its 200-day moving average is $70.76. The company has a market cap of $8.29 billion, a P/E ratio of 23.84, a PEG ratio of 1.53 and a beta of 0.94. Encompass Health has a 52 week low of $57.55 and a 52 week high of $85.84. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.19.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.19. The firm had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.27 billion. Encompass Health had a net margin of 7.33% and a return on equity of 17.69%. The business's revenue was up 13.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.88 earnings per share. As a group, analysts predict that Encompass Health will post 3.96 EPS for the current year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a dividend of $0.15 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $0.60 dividend on an annualized basis and a yield of 0.73%. Encompass Health's payout ratio is 17.29%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.